RICHARD BOWEN: Open Payments
NPI 1497347975 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 136 payments from 17 companies in 2025. Trend: 2023 $2,483 · 2024 $3,538 · 2025 $2,639
Food & beverage: $2,539Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $548 |
| ABBVIE INC. | 19 | $488 |
| Verrica Pharmaceuticals Inc. | 46 | $388 |
| UCB, Inc. | 13 | $214 |
| Janssen Scientific Affairs, LLC | 2 | $144 |
| GENZYME CORPORATION | 6 | $144 |
| E.R. Squibb & Sons, L.L.C. | 2 | $142 |
| Regeneron Healthcare Solutions, Inc. | 5 | $132 |
| LEO Pharma Inc. | 3 | $110 |
| Incyte Corporation | 4 | $68 |
Products named: TREMFYA, YCANTH, SKYRIZI, DUPIXENT, RINVOQ, Bimzelx, Sotyktu, ANZUPGO.
Industry payments across CA — which companies pay providers there.
